Rare diseases
Investigational molecules
Locations
5300 Memorial Drive Ste 950, 77007-8274, United States
Moleculin Biotech Inc. focuses its clinical research on acute myeloid leukemia, with studies in adults who have refractory or relapsed AML and in patients receiving first-line therapy.
The sponsor’s research activity centers on treatment settings where disease control remains difficult, especially in adult hematologic malignancy care.
Moleculin Biotech Inc. runs clinical trials in conditions such as Acute myeloid leukaemia, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study of L-Annamycin and Cytarabine for Adults with Refractory or Relapsed Acute Myeloid Leukemia
BelgiumStudy of liposomal annamycin and cytarabine combination for patients with acute myeloid leukemia (AML) who are newly diagnosed or have not responded to previous treatment
ItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
